Widening for clopidogrel BE study [Outliers]

posted by mittyri – Russia, 2021-06-16 18:04 (1041 d 15:35 ago) – Posting: # 22419
Views: 4,002

Dear Loky do

❝ is widening of Cmax accepted in clopidogrel BE studies with fully replicate design or not?


You linked the EMA Q&A where it is stated unequivocally:
Under these circumstances, the widening of 90% confidence intervals for Cmax is not recommended.

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
22,990 posts in 4,826 threads, 1,665 registered users;
52 visitors (0 registered, 52 guests [including 4 identified bots]).
Forum time: 09:39 CEST (Europe/Vienna)

If you don’t like something change it;
if you can’t change it, change the way you think about it.    Mary Engelbreit

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5